Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bioage Labs Inc (BIOA)

Bioage Labs Inc (BIOA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
BioAge Labs to Participate in Upcoming Investor Conferences in December 2024

BioAge Labs will present at two investor conferences in December 2024, focusing on aging-related metabolic disease therapies.Quiver AI SummaryBioAge Labs, a clinical-stage biopharmaceutical company focused...

BIOA : 18.44 (+0.22%)
BioAge Labs to Present at Upcoming Investor Conferences

BIOA : 18.44 (+0.22%)
BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates

BIOA : 18.44 (+0.22%)
BioAge Labs to Present Preclinical Data for APJ Agonist Azelaprag at ObesityWeek 2024

BIOA : 18.44 (+0.22%)
BioAge Labs to Present at Jefferies London Healthcare Conference

BIOA : 18.44 (+0.22%)
Prediction: These 2 Stocks Could Soar in 2025

The key word here is "could."

BIOA : 18.44 (+0.22%)
RXRX : 5.75 (-4.80%)
GLP-1 Stocks Aren't the Only Way to Benefit From the Weight Loss Drugs Boom

The future of the weight loss market might not revolve around GLP-1 drugs.

BIOA : 18.44 (+0.22%)
LLY : 749.92 (-0.46%)
ZLDPF : 99.3200 (-1.66%)
Interested in Weight Loss Stocks Besides Novo Nordisk and Eli Lilly? You Might Want To Check Out This New IPO Stock

BioAge Labs is the latest pharmaceutical company looking to make waves in the weight loss realm.

BIOA : 18.44 (+0.22%)
LLY : 749.92 (-0.46%)
Three Biotech Startups Plan $400 Million U.S. IPOs Amid Sector Resurgence

Three healthcare startups are aiming to raise up to $400 million through their U.S. initial public offerings, highlighting a strong resurgence in the biotech sector after a two-year downturn. September...

BIOA : 18.44 (+0.22%)
BCAX : 17.77 (-3.32%)
2 Next-Gen Weight Loss Stocks That Are Worth Buying Right Now

One of these businesses is a risky play, but the other is very likely to succeed.

BIOA : 18.44 (+0.22%)
LLY : 749.92 (-0.46%)

Barchart Exclusives

S&P Futures Tick Lower Ahead of U.S. PMI Data
December S&P 500 E-Mini futures (ESZ24) are trending down -0.24% this morning as weak Eurozone PMI data cast doubt on the health of the global economy, while investors braced for U.S. business activity data. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar